Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion type Assertion NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_head.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_provenance.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion evidence source_evidence_literature NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_provenance.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion SIO_000772 8639762 NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_provenance.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion wasDerivedFrom befree-20140225 NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_provenance.
- NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_assertion wasGeneratedBy ECO_0000203 NP718037.RApOCg6zbYzdmsFqZQckJtnvyJjMsWKC48M9ecpZRmisg130_provenance.